Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese south Indian men: An indication for increased cardiovascular risk

Acta Physiologica Hungarica

Volumn 101, Issue 1, 2014, Pages 13-20

  Ikkruthi, S ^a   Rajappa, Medha ^a   Nandeesha, H ^a   Satheesh, S ^a   Sundar, I ^a   Ananthanarayanan, P ^a   Harichandrakumar, K ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

apolipoproteins; homocysteine; lipid pentad index and lipid tetrad index; Lp(a); obesity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LIPOPROTEIN A;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROGENIC INDEX OF PLASMA; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HIP CIRCUMFERENCE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPOPROTEINEMIA; INDIAN; LIPID BLOOD LEVEL; LIPID PENTAD INDEX; LIPID TETRAD INDEX; LIPOPROTEIN BLOOD LEVEL; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; WAIST CIRCUMFERENCE;

APOLIPOPROTEINS; HOMOCYSTEINE; LIPID PENTAD INDEX AND LIPID TETRAD INDEX; LP(A); OBESITY;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPOPROTEINEMIAS; INDIA; LIPOPROTEIN(A); MALE; OBESITY; RISK FACTORS; UP-REGULATION; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84896338181     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.100.2013.017     Document Type: Article

References (27)

1. Balogh E, Bereczky Z, Katona E, Koszegi Z, Edes I, Muszbek L, Czuriga I: Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a casecontrol study. Thromb. Res. 129, 133-138 (2012)
2. Baños-González MA, Anglés-Cano E, Cardoso-Saldaña G, Peña-Duque MA, Martínez-Ríos MA, Valente-Acosta B, González-Pacheco H, de la Peña-Díaz A: Lipoprotein (a) and homocysteine potentiate the risk of coronary artery disease in male subjects. Circ. J. 76, 1953-1957 (2012)
3. Bendini MG, Lanza GA, Mazza A, Giordano A, Leggio M, Menichini G et al.: Risk factors for cardiovascular diseases: what is the role for homocysteinefi G. Ital. Cardiol. 8, 148-160 (2007)
4. Cabrinety N, Pisonero MJ, Ajram J, Armenteras A, Cuatrecasas JM: Lp(a) in obese children with a family history of cardiovascular disease. J. Pediatr. Endocrinol. Metab. 15, 77-80 (2002).
5. Chow CK, Joshi R, Celermajer DS, Patel A, Neal BC: Recalibration of a Framingham risk equation for a rural population in India. J. Epidemiol. Community Health 63, 379-385 (2009)
6. Das B, Daga MK, Gupta SK: Lipid Pentad Index: A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India. Clin. Biochem. 40, 18-24 (2007)
7. Donatelli M, Verga S, Vaccaro M, Russo V, Bucalo ML, Scarpinato A: Serum lipoprotein Lp(a) in obesity. Diabetes Res. 20, 127-131 (1992)
8. Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL: Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler. Thromb. Vasc Biol. 20, 493-499 (2000)
9. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972)
10. Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK: Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiol. 63, 749-755 (2008)
11. Hajjar KA, Gavish D, Breslow JL, Hachman RL: Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339, 303-305 (1989)
12. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler. Thromb. Vasc. Biol. 18, 133-138 (1998)
13. Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, Vaduganathan M, Rao RS, Koschinsky M, Morrisett JD: Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J. Lipid Res. 42, 631-638 (2001)
14. Hu YM, Tian HM, Liu R, Chen X: Atherogenic index of plasma is associated with carotid intimamedia thickness in patients with type 2 diabetes mellitus. Sichuan Da Xue Xue Bao Yi Xue Ban 35, 696-698, 707 (2004)
15. Hughes K, Tar-Choon Aw, Kuperan P, Choo M: Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J. Epidemiol. Community Health. 51, 394-399 (1997)
16. Lee YH, Pratley RE: Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J. Cardiopulm. Rehabil. Prev. 27, 2-10 (2007)
17. Nardulli M, Durlach V, Pepe G, Anglés-Cano E: Mechanism for the homocysteineenhanced antifibrinolytic potential of lipoprotein(a) in human plasma. Thromb. Haemost. 94, 75-81 (2005)
18. Nandeesha H, Sathiyapriya V, Bobby Z, Selvaraj N, Pavithran P, Agrawal A: Atherogenic lipid risk factors in men classified as overweight and obese according to the preliminary WHO guidelines for Asians. Indian J. Physiol. Pharmacol. 52, 205-208 (2008)
19. Rajappa M, Sridhar MG, Balachander J, Sethuraman KR: Lp(a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India. Clin. Chim. Acta 372, 70-75 (2006)
20. Ramjee V, Sperling LS, Jacobson TA: Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math. J. Am. Coll. Cardiol. 58, 457-463 (2011)
21. Scanu AM, Lawn RM, Berg K: Lipoprotein(a) and atherosclerosis. Ann. Intern. Med. 115, 209-218 (1991)
22. Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G: Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361, 777-780 (2003)
23. Tayal D, Goswami B, Koner BC, Mallika V: Role of homocysteine and lipoprotein (a) in atherosclerosis: an update. Biomed. Res. 22, 391-405 (2011)
24. Vaya A, Eiarque I, Tembl J, Corella D, Liaz B: Hyperhomocysteinemia, obesity and cryptogenic stroke. Clin. Hemorheol. Microcirc. 47, 53-58 (2011)
25. Vayá A, Rivera L, Hernández-Mijares A, de la Fuente M, Solá E, Romagnoli M, Alis R, Laiz B: Homocysteine levels in morbidly obese patients. Its association with waist circumference and insulin resistance. Clin. Hemorheol. Microcirc. 52, 49-56 (2012)
26. Wallefeldt K, Bokemark L, Wikstrand J, Hulthe J, Fagerberg B: Apolipoprotein B/Apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intimamedia thickness during 3 years in middle-aged men. Stroke 35, 2248-2252 (2004)
27. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847 (1998)